TREATMENT OF CANCER VIA TARGETING OF IL-13 RECEPTOR-a2

摘要

Disclsoed herein are compositions and methods for treating or preventing cancer involving the use of a TNF-alpha antagonist, an IL- 13Ra2 antagonist, and/or a AP-I antagonist.